AbbVie 2023 J.P. Morgan Healthcare Conference

AbbVie presented at the J.P. Morgan Healthcare Conference on January 10, 2023, showcasing its diversified biopharmaceutical portfolio across Immunology, Oncology, Neuroscience, Aesthetics, and Eye Care. The company outlined a clear path to long-term growth following U.S. Humira loss of exclusivity, with expectations for return to strong top-line growth in 2025 and high-single-digit CAGR through the remainder of the decade.